Therapeutic effects of Argyrin F in pancreatic adenocarcinoma.
Chen, Xi
Therapeutic effects of Argyrin F in pancreatic adenocarcinoma. [electronic resource] - Cancer letters 07 2017 - 20-28 p. digital
Publication Type: Journal Article
1872-7980
10.1016/j.canlet.2017.04.003 doi
Animals
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Carcinoma, Pancreatic Ductal--blood supply
Cell Line, Tumor
Cell Movement--drug effects
Cell Proliferation--drug effects
Cyclin-Dependent Kinase Inhibitor p21--metabolism
Cyclin-Dependent Kinase Inhibitor p27--metabolism
Cyclooxygenase 2--metabolism
Dose-Response Relationship, Drug
G1 Phase Cell Cycle Checkpoints--drug effects
Humans
Mice, Transgenic
Neoplasm Invasiveness
Neovascularization, Pathologic
Pancreatic Neoplasms--blood supply
Peptides, Cyclic--pharmacology
Protein Stability
Signal Transduction--drug effects
Time Factors
Tumor Burden--drug effects
Therapeutic effects of Argyrin F in pancreatic adenocarcinoma. [electronic resource] - Cancer letters 07 2017 - 20-28 p. digital
Publication Type: Journal Article
1872-7980
10.1016/j.canlet.2017.04.003 doi
Animals
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Carcinoma, Pancreatic Ductal--blood supply
Cell Line, Tumor
Cell Movement--drug effects
Cell Proliferation--drug effects
Cyclin-Dependent Kinase Inhibitor p21--metabolism
Cyclin-Dependent Kinase Inhibitor p27--metabolism
Cyclooxygenase 2--metabolism
Dose-Response Relationship, Drug
G1 Phase Cell Cycle Checkpoints--drug effects
Humans
Mice, Transgenic
Neoplasm Invasiveness
Neovascularization, Pathologic
Pancreatic Neoplasms--blood supply
Peptides, Cyclic--pharmacology
Protein Stability
Signal Transduction--drug effects
Time Factors
Tumor Burden--drug effects